ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Sichuan Biokin Pharmaceutical Co., Ltd. clinical trials

Also known as Baili.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 146 studies whose lead sponsor is Sichuan Biokin Pharmaceutical Co., Ltd. or one of 2 companies grouped under it. 100 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 18, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Sichuan Biokin Pharmaceutical with Takeda and Hoffmann-La Roche →

Pipeline: 19 programs

Each counted once: 19 with a study Sichuan Biokin Pharmaceutical Co., Ltd. leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 5 of 7 with the most live studies.

Program
izalontamab brengitecanPhase 3 · 50 live · Carcinoma, Non-Small-Cell Lung · primary completion Nov 2026☆ Track
trastuzumab brengitecanPhase 3 · Sichuan Biokin Pharmaceutical Co., Ltd.: Phase 3 · 21 live · Breast Neoplasms · primary completion Dec 2026☆ Track
Anti-CD33 Antibody-drug Conjugate BL-M11D1Phase 3 · Sichuan Biokin Pharmaceutical Co., Ltd.: Phase 1 · 3 live · Leukemia, Myeloid, Acute · primary completion Dec 2026☆ Track
Anti-DLL3 Antibody-drug Conjugate BL-M14D1Phase 3 · Sichuan Biokin Pharmaceutical Co., Ltd.: Phase 3 · 2 live · Small Cell Lung Carcinoma · primary completion Dec 2027☆ Track
CytarabinePhase 3 · 1 live · Leukemia, Myeloid, Acute · primary completion Dec 2027☆ Track

2 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Sichuan Biokin Pharmaceutical Co., Ltd.’s own registered studies; “Sichuan Biokin Pharmaceutical Co., Ltd. says” is its pipeline, which lists phases by indication. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

Licenses and deals

One of Sichuan Biokin Pharmaceutical’s programs has a dated deal behind it: 1 licensed out. Each from the companies’ own releases and filings, linked; the registry does not record them.

Licensed out 1

What it is testing

The drugs Sichuan Biokin Pharmaceutical Co., Ltd.’s studies test, most open studies first — 30 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

Coming up

50 of Sichuan Biokin Pharmaceutical Co., Ltd.’s studies under way reach primary completion within a year, 7 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 2N’26
  2. 29D
  3. 1J’27
  4. 1F
  5. M
  6. A
  7. 6M
  8. 9J
  9. 1J
  10. A
  11. S
  12. O
  13. 1N

The 12 nearest

Show 7 more

Add all 50 to your calendar (.ics) → With an account.

All 146 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now10068%Recruiting 84 · Not yet recruiting 16
  • Under way, not recruiting3927%
  • Completed11%
  • Stopped early43%Terminated 3 · Withdrawn 1
  • Status unknown or other21%

Phase

  • Phase 172
  • Phase 263
  • Phase 336
  • Phase 41

Where

  • China136
  • United States10
  • Spain2
  • Georgia2
  • France2
  • Italy2

Over the years

  1. 19
  2. 20
  3. 21
  4. 22
  5. 23
  6. 24
  7. 25
  8. 4326

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Sichuan Biokin Pharmaceutical Co., Ltd.

  • Sichuan Baili Pharmaceutical Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    136 studies →
  • SystImmune Inc.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    10 studies →

Focus areas

Conditions Sichuan Biokin Pharmaceutical Co., Ltd. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 146. Browse all 146 →